KM Research Hub

LITERATURE

原始候选快照

v3 复核前的候选池,完整保留,仅供查看,不会自动重新处理。 共 7004 篇。

导出 CSV
论文标识日期入排置信度入排依据KM 状态
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial.Diabetes Metab JPMID 38763510PMC113071222024-Jul0.98未发现恶性肿瘤人群证据。待处理
Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial.Lancet NeurolPMID 38768621无 PMCID2024-Jul0.98未发现恶性肿瘤人群证据。待处理
Model-Informed Clinical Development of 6-Monthly Injection of Paliperidone Palmitate in Patients with Schizophrenia: Dosing Strategies Guided by Population Pharmacokinetic Modeling and Simulation (Part II).Eur J Drug Metab PharmacokinetPMID 38769284无 PMCID2024-Jul0.98未发现恶性肿瘤人群证据。待处理
Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.Adv TherPMID 38775925PMC112137512024-Jul0.98未发现恶性肿瘤人群证据。待处理
Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.Lancet NeurolPMID 38782015无 PMCID2024-Jul0.98未发现恶性肿瘤人群证据。待处理
Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial.Lancet HIVPMID 38788744PMC117005622024-Jul0.98未发现恶性肿瘤人群证据。待处理
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial.Int J HematolPMID 38796666PMC112265302024-Jul0.98未发现恶性肿瘤人群证据。待处理
Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus placebo in mild to moderate anxiety subjects: A double blind multicenter randomized clinical trial.Asian J PsychiatrPMID 38797087无 PMCID2024-Jul0.98未发现恶性肿瘤人群证据。待处理
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.Adv TherPMID 38802635PMC112137362024-Jul0.98未发现恶性肿瘤人群证据。待处理
Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial.Oral OncolPMID 38820889无 PMCID2024-Jul0.85The record is from a definitive randomized controlled oncology trial, but it reports on a secondary analysis of a toxicity outcome (risk prediction model for cisplatin-induced AKI) rather than a primary or secondary efficacy endpoint like overall survival, progression-free survival, or recurrence.待处理
Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer with PD-L1 ≥ 1 %: A subgroup analysis from the EMPOWER-Lung 3 part 2 trial.Lung CancerPMID 38820979无 PMCID2024-Jul0.96属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。待处理
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Stapokibart in Healthy Volunteers and Adult Subjects with Atopic Dermatitis.Adv TherPMID 38833140无 PMCID2024-Jul0.98未发现恶性肿瘤人群证据。待处理
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial.Ann HematolPMID 38842566PMC112240742024-Jul0.98未发现恶性肿瘤人群证据。待处理
Dendritic cells loaded with allogeneic tumour cell lysate plus best supportive care versus best supportive care alone in patients with pleural mesothelioma as maintenance therapy after chemotherapy (DENIM): a multicentre, open-label, randomised, phase 2/3 study.Lancet OncolPMID 38848742无 PMCID2024-Jul0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Acute Intermittent Hypoxia With High-Intensity Gait Training in Chronic Stroke: A Phase II Randomized Crossover Trial.StrokePMID 38860389PMC111962002024-Jul0.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of mixture of ivy leaf extract and coptidis rhizome in the treatment of acute bronchitis: multicenter, randomized, double-blinded, active-controlled, parallel, therapeutic confirmatory clinical trial.Curr Med Res OpinPMID 38889376无 PMCID2024-Jul0.98未发现恶性肿瘤人群证据。待处理
Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group.Lancet OncolPMID 38936378PMC115508932024-Jul0.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Efficacy and Safety of BP02 (Trastuzumab Biosimilar) in HER2-Positive Metastatic Breast Cancer: A Multicenter Phase III Study.Clin Drug InvestigPMID 38937403PMC112632192024-Jul0.95Study is an original, randomized, Phase III oncology trial of a drug (biosimilar) intervention with a primary efficacy endpoint of objective response rate (categorical), not a time-to-event endpoint (OS, PFS, DFS, etc.) with Kaplan-Meier or HR reporting.待处理
Effects of ganaxolone on non-seizure outcomes in CDKL5 Deficiency Disorder: Double-blind placebo-controlled randomized trial.Eur J Paediatr NeurolPMID 38959712PMC112833502024-Jul0.98未发现恶性肿瘤人群证据。待处理
Morbidity and Mortality After Laparoscopy-Assisted Distal Gastrectomy and Totally Laparoscopic Distal Gastrectomy to Treat Gastric Cancer: An Interim Report: A Phase III Multicenter, Prospective, Randomized Trial (The KLASS-07 Trial).J Gastric CancerPMID 38960885PMC112247182024-Jul0.93干预为非药物单独策略,未满足药物干预要求。待处理
Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa.J Int AIDS SocPMID 38978403PMC112314452024-Jul0.98未发现恶性肿瘤人群证据。待处理
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy.Circ Heart FailPMID 38979608PMC112447532024-Jul0.98未发现恶性肿瘤人群证据。待处理
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.LancetPMID 38851203无 PMCID2024-Jun-291.00All required criteria are explicitly met: oncology, human, randomized, Phase III, time-to-event endpoint, drug intervention, and original result report.待处理
Re-examining the factor structure of the Insomnia Severity Index (ISI) and defining the meaningful within-individual change (MWIC) for subjects with insomnia disorder in two phase III clinical trials of the efficacy of lemborexant.J Patient Rep OutcomesPMID 38951287PMC112172512024-Jun-290.98未发现恶性肿瘤人群证据。待处理
Difelikefalin improves itch-related sleep disruption in patients undergoing haemodialysis.Nephrol Dial TransplantPMID 37968132PMC112109842024-Jun-280.98未发现恶性肿瘤人群证据。待处理
Heterogeneity of treatment effect of vilobelimab in COVID-19: a secondary analysis of a randomised controlled trial.Crit CarePMID 38943192PMC112142482024-Jun-280.98未发现恶性肿瘤人群证据。待处理
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation.N Engl J MedPMID 38767614无 PMCID2024-Jun-270.98未发现恶性肿瘤人群证据。待处理
Reteplase versus Alteplase for Acute Ischemic Stroke.N Engl J MedPMID 38884332无 PMCID2024-Jun-270.98未发现恶性肿瘤人群证据。待处理
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.N Engl J MedPMID 38924731无 PMCID2024-Jun-270.98未发现恶性肿瘤人群证据。待处理
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.N Engl J MedPMID 38924732无 PMCID2024-Jun-270.98未发现恶性肿瘤人群证据。待处理
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL.Blood AdvPMID 38607410PMC112256762024-Jun-250.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.J Pediatr Endocrinol MetabPMID 38717038无 PMCID2024-Jun-250.98未发现恶性肿瘤人群证据。待处理
S100 proteins as potential predictive biomarkers of abatacept response in polyarticular juvenile idiopathic arthritis.Arthritis Res TherPMID 38918871PMC111972422024-Jun-250.98未发现恶性肿瘤人群证据。待处理
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial.LancetPMID 38824941无 PMCID2024-Jun-220.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.LancetPMID 38843860PMC117403962024-Jun-220.95The trial meets criteria for oncology, human, randomized, phase 3, drug intervention, and original result. However, it is excluded because the primary efficacy endpoint is objective response rate (ORR), which is not a time-to-event endpoint. The abstract does not report a time-to-event outcome like OS, PFS, DFS, EFS, RFS, or TTP, nor does it mention Kaplan-Meier estimates or hazard ratios for such an endpoint.待处理
Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS).Br J DermatolPMID 38133615无 PMCID2024-Jun-200.98未发现恶性肿瘤人群证据。待处理
Efficacy and safety of bilastine vs. levocetirizine for the treatment of chronic idiopathic urticaria: A multicenter, double-blind, double-dummy, phase III, non-inferiority, randomized clinical trial.Chin Med J (Engl)PMID 38557589PMC111888622024-Jun-200.98未发现恶性肿瘤人群证据。待处理
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease.J Clin OncolPMID 38603646无 PMCID2024-Jun-200.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A SARS-CoV-2 recombinant spike protein vaccine (S-268019-b) for COVID-19 prevention during the Omicron-dominant period: A phase 3, randomised, placebo-controlled clinical trial.VaccinePMID 38734495无 PMCID2024-Jun-200.98未发现恶性肿瘤人群证据。待处理
Bilastine 0.6% Preservative-free Eye Drops: A Once-daily Treatment for Allergic Conjunctivitis.J Investig Allergol Clin ImmunolPMID 36811846无 PMCID2024-Jun-170.98未发现恶性肿瘤人群证据。待处理
Tirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).J Clin Endocrinol MetabPMID 38252888PMC111805002024-Jun-170.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial.J Clin PsychiatryPMID 38917366无 PMCID2024-Jun-170.98未发现恶性肿瘤人群证据。待处理
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.LancetPMID 38768626无 PMCID2024-Jun-150.98未发现恶性肿瘤人群证据。待处理
Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons.Clin Infect DisPMID 38253338PMC111756692024-Jun-140.98未发现恶性肿瘤人群证据。待处理
Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).Clin Infect DisPMID 38297916无 PMCID2024-Jun-140.98未发现恶性肿瘤人群证据。待处理
A Randomized, Double-Blind, Phase 3 Safety and Efficacy Study of Ridinilazole Versus Vancomycin for Treatment of Clostridioides difficile Infection: Clinical Outcomes With Microbiome and Metabolome Correlates of Response.Clin Infect DisPMID 38305378PMC111756832024-Jun-140.98未发现恶性肿瘤人群证据。待处理
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.Clin Infect DisPMID 38462673PMC111756872024-Jun-140.98未发现恶性肿瘤人群证据。待处理
Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.Clin Infect DisPMID 38478634PMC111756742024-Jun-140.98未发现恶性肿瘤人群证据。待处理
Axicabtagene ciloleucel vs standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume.BloodPMID 38557775PMC112082952024-Jun-130.98原始人体肿瘤 Phase III 随机药物试验,并报告 time-to-event 疗效结局。待处理
A single-center, assessor-blinded, randomized controlled clinical trial to test the safety and efficacy of a novel brain-computer interface controlled functional electrical stimulation (BCI-FES) intervention for gait rehabilitation in the chronic stroke population.BMC NeurolPMID 38872109PMC111708002024-Jun-130.98未发现恶性肿瘤人群证据。待处理